Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy

Infect Dis (Lond). 2020 Mar;52(3):216-218. doi: 10.1080/23744235.2019.1693624. Epub 2019 Nov 26.

Authors

A R Buonomo¹, G Viceconte¹, R Scotto¹, M De Angelis², S Tozza², F Manganelli², A G Lanza³, G G Di Costanzo³, I Gentile¹

Affiliations

¹ Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy.
² Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
³ Hepatology Unit, Cardarelli Hospital, Naples, Italy.

PMID: 31766959
DOI: 10.1080/23744235.2019.1693624

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acute-On-Chronic Liver Failure / etiology*
Fatal Outcome
Hepatitis B / complications*
Hepatitis B / immunology*
Hepatitis B Antibodies / blood
Hepatitis B Core Antigens / immunology
Hepatitis B Surface Antigens / immunology
Humans
Immunoglobulin G / blood
Immunologic Factors / adverse effects*
Male
Middle Aged
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy
Recurrence
Rituximab / adverse effects*

Substances

Hepatitis B Antibodies
Hepatitis B Core Antigens
Hepatitis B Surface Antigens
Immunoglobulin G
Immunologic Factors
Rituximab